Home » Topics » Regulatory

Regulatory
RSS

Abilify approved for acute bipolar mania

Oct. 5, 2004

FDA approves Remicade as first-line therapy in moderate to severe RA

Oct. 5, 2004

Enbrel approved in E.U. for psoriasis

Oct. 5, 2004

Third indication studied for SGN-30 in new phase II trial

Sep. 29, 2004

Expanded indication for Eloxatin for early stage colon cancer treatment

Sep. 21, 2004

Nexium completes European mutual recognition procedure for new indications

Sep. 20, 2004

Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis

Sep. 9, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Clarinex syrup approved for use in children with allergies, hives

Sep. 3, 2004

sNDA submission for Merrem for complicated skin and skin structure infections

Aug. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...